Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

ACE-inhibitors, β-blockers, implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) improved prognosis of heart failure. We sought to analyse the long-term prognostic impact of evidence-based integrated therapeutic strategies in patients with idiopathic dilated cardiomyopathy (IDCM).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur. J. Heart Fail.

Title: European journal of heart failure

ISSN (Electronic): 1879-0844

ISSN (Print): 1388-9842

Publication date (Electronic): Mar 2014

Volume: 16

Issue: 3

Affiliations

[1 ] Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, 34149, Italy.

Article

DOI: 10.1002/ejhf.16

PubMed ID: 24464640

SO-VID: 5aad45cb-4d7b-49e7-a302-fa367e0b8d49

History

Keywords: Dilated cardiomyopathy,Follow-up study,Heart failure,Prognosis,Sudden death

Data availability:

Keywords: Dilated cardiomyopathy, Follow-up study, Heart failure, Prognosis, Sudden death

Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.

Read this article at

Abstract

Related collections

cGMP: Generators, Effectors and Therapeutic Implications Conference

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 64